Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study

T. Koga(University Health Network), Tetsuya Mitsudomi(Kindai University)

Translational Lung Cancer Research

July 23, 2021

10.21037/tlcr-21-216

Cited by 14

Related Papers

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

|Journal of Thoracic Oncology|2011|4.8k

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

|Science|2007|4.5k

Reduced Expression of the <b> <i>let-7</i> </b> MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

|Cancer Research|2004|2.4k

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

|The Lancet|2022|1.6k

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

|Journal of Thoracic Oncology|2011|656